Corbus Pharmaceuticals Newsroom

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Corbus Pharmaceuticals (CRBP) and Fortrea Holdings Inc. (FTRE)

TipRanksDec 17 18:30 · Ratings

Promising Potential of Corbus Pharmaceuticals: Buy Rating Reinforced by Key Assets and Strategic Focus

TipRanksDec 12 15:15 · Ratings

Express News | Corbus Pharmaceuticals Announces Dosing of First Patient in Its First-in-Human Study of Crb-601 to Treat Patients With Advanced Solid Tumors

BreakingsDec 9 20:00

Corbus Pharmaceuticals Announces Dosing of First Patient in Its First-In-Human Study of CRB-601 to Treat Patients With Advanced Solid Tumors

Corbus PharmaceuticalsDec 9 13:00

Corbus Pharmaceuticals Receives Fast Track From FDA for Cervical Cancer Treatment

WSJDec 3 20:20

Express News | Corbus Pharmaceuticals Holdings Inc - First Data From Dose Escalation Study Expected in Q1 2025

BreakingsDec 3 20:04

Express News | FDA Grants Fast Track Designation to Crb-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

BreakingsDec 3 20:00

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

Corbus PharmaceuticalsDec 3 13:00

Corbus Pharmaceuticals Analyst Ratings

BenzingaDec 2 18:46 · Ratings

Piper Sandler Initiates Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Announces Target Price $35

Futu NewsDec 2 18:34 · Ratings

Express News | Corbus Pharmaceuticals Holdings Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $35

BreakingsDec 2 17:15

Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now

Yahoo FinanceNov 26 19:54

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference

GlobeNewswireNov 21 21:00

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GlobeNewswireNov 12 21:00

We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate

Yahoo FinanceNov 9 22:39

RBC Capital Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $65

Futu NewsNov 9 10:32 · Ratings

Corbus Pharmaceuticals (CRBP) Receives a Buy From RBC Capital

TipRanksNov 9 09:47 · Ratings

Oppenheimer Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $60

Futu NewsNov 8 12:32 · Ratings

Corbus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 8 06:08 · Announcements

H.C. Wainwright Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Cuts Target Price to $75

Futu NewsNov 8 00:31 · Ratings